This Solicitation opportunity from Government of Canada was posted on January 31, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

RFP - Manufacture and Supply of Buffered Diluent containing Glycerol and Sterile Empty Vials with Cap Enclosure

Closed

WS4617512505International

Submission Closed02/20/2025, 02:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

International

Compounded Antimicrobial Homecare Supply and ServiceThe Compounded Antimicrobial Homecare Supply and Service subcontract, issued by the Leeds Teaching Hospitals NHS Trust, involves the production and supply chain management of unlicensed compounded antimicrobial medicines. The selected provider will utilize specialized pharmaceutical compounding facilities to prepare these agents and manage the delivery process for patients within the NEY region as part of NEYPPC High Tech Homecare projects. To qualify, the provider must hold the necessary pharmaceutical manufacturing licenses and maintain strict adherence to NHS and NEYPPC homecare standards. The scope of work encompasses both the delivery of the compounded medications and the provision of essential homecare support services to ensure patient safety and treatment efficacy.

Leeds Teaching Hospitals NHS Trust

POSTED

DEADLINE

Compounded Desferrioxamine Homecare Supply and ServiceThis subcontract, titled Compounded Desferrioxamine Homecare Supply and Service, is issued by the Leeds Teaching Hospitals NHS Trust. The selected provider will be responsible for the compounding of unlicensed Desferrioxamine medicines within specialized pharmaceutical facilities and the subsequent management of the high-tech supply chain to ensure delivery to patients within the NEY region. This role involves supporting prime contractors on NEYPPC High Tech Homecare projects by providing both the compounded medications and necessary homecare support services. To qualify for this contract, the provider must hold the required pharmaceutical manufacturing licenses and maintain strict adherence to NHS and NEYPPC homecare standards. The opportunity was posted on November 13, 2026, with a response deadline of November 16, 2026. The work falls under NAICS code 325412, focusing on the specialized production and distribution of pharmaceutical products for home-based patient care.

Leeds Teaching Hospitals NHS Trust

POSTED

DEADLINE

IV Fluid Pharmaceutical Supplier

Navajo Area Indian Health Svc

POSTED

DEADLINE

Bulk F-18 FDG SupplyThis subcontract, managed by the Department of Veterans Affairs Network Contract Office 22, involves the manufacture and delivery of bulk F-18 FDG to support nuclear medicine projects at the VA Loma Linda Healthcare System. The selected provider is responsible for supplying bulk quantities of the radioactive material for facility-based processing, ensuring all shipments include packing slips and Material Safety Data Sheets. To maintain operational compatibility, all products must be bar-coded for the NMIS System. Strict regulatory compliance is required for this engagement, including mandatory FDA clearance and specialized certifications for the high-volume transport of radioactive materials. The contract falls under NAICS code 325412 and is centered in Loma Linda, California. Interested parties should note the response deadline of November 20, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

F18 NaF Radiopharmaceutical SupplyThis subcontract involves the manufacture and supply of F18 NaF Sodium Fluoride radiopharmaceuticals for prime contractors supporting nuclear medicine projects at the VA Loma Linda Healthcare System. The selected provider is responsible for the production and delivery of doses, ensuring all products are bar-coded for NMIS System compatibility and accompanied by the necessary packing slips and Material Safety Data Sheets. The contract mandates strict compliance with FDA clearance requirements and rigorous protocols for the transport and handling of radioactive materials. Managed by the Department of Veterans Affairs Network Contract Office 22, the performance of these services will take place in Loma Linda, California, under NAICS code 325412.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

18-FDG Radiopharmaceutical SupplyThis subcontract involves the manufacture and supply of 18-FDG Fluorodeoxyglucose radiopharmaceuticals for prime contractors supporting nuclear medicine projects at the VA Loma Linda Healthcare System. The selected provider is responsible for the production and delivery of doses, ensuring all products are bar-coded for compatibility with the NMIS System and accompanied by the necessary packing slips and Material Safety Data Sheets. The contractor must maintain FDA clearance and strictly adhere to all established protocols regarding the transport and handling of radioactive materials. Managed by the Department of Veterans Affairs Network Contract Office 22, the performance of this contract takes place in Loma Linda, California, under NAICS code 325412.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

BPA for IV Fluids on an "As Needed Basis"

Solicitation # SSN-CPSU-1533180

The Indian Health Service Crownpoint Service Unit is conducting a sources-sought notice to identify capable firms for a Blanket Purchase Agreement to provide IV fluids on an as-needed basis for the General Services Department. The anticipated contract structure consists of a base year followed by four option years. This market research effort is primarily focused on identifying Indian-owned economic enterprises, including both large and small entities, under the Buy Indian Act, though other capable firms are invited to respond. The requirement is classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, with a small business size standard of 1,300 employees. Interested parties must submit their response by November 23, 2026, to Arlynda Largo. Submissions must include a comprehensive company profile detailing the Unique Entity Identifier, business size, ownership type, and socioeconomic status, along with a statement of capabilities and past performance history. Specifically, Indian-owned enterprises must provide a completed IHS IEE Representation Form to self-certify their eligibility under HHSAR 326.601. All potential offerors must be registered in the System for Award Management at the time of submission and award.

Navajo Area Indian Health Svc

POSTED

DEADLINE

6505--VA Loma Linda FDG

Solicitation # 36C26227Q0133

The Department of Veterans Affairs Loma Linda Healthcare System is conducting a Sources Sought and Request for Information (RFI) to identify qualified sources for a future single-award, Firm Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract. The scope of work involves the procurement of radiopharmaceutical supplies, specifically 18-FDG, F18 NaF, and Bulk F-18 FDG. The intended period of performance consists of a base year starting December 15, 2026, followed by four option years ending December 14, 2031. The government is seeking providers capable of delivering sterile doses for intravenous injection that are compatible with the NMIS System and meet strict quality standards, including a radioactivity variance no greater than plus or minus 20 percent at the time of calibration. Deliveries will be made to the Nuclear Medicine Section at the Loma Linda facility, with routine orders required by the next business day and emergency orders required on the same day. The contractor must be licensed by the State of Operation and the Nuclear Regulatory Commission or an Agreement State Agency, and delivery personnel must be trained in Department of Transportation requirements and radiation safety. Interested parties must submit a capabilities statement, business size representations under NAICS 325412, and SAM.gov entity information to [email hidden] by November 20, 2026. This notice is for planning purposes only and does not constitute a formal solicitation.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Hydrogen Peroxide Topical Solution SupplierThis subcontract involves the supply of 3% strength Hydrogen Peroxide Topical Solution for prime contractors supporting Department of Defense projects under the Medical Supply Chain Pharm FSA. The supplier is responsible for manufacturing or sourcing the liquid solution in 4-ounce bottles, delivered in cases of 24. Strict quality and storage requirements are mandated, including maintaining a temperature between 20 and 25 degrees Celsius and ensuring a minimum shelf life of 21 months upon receipt. The contractor must adhere to OTC pharmaceutical standards, the Buy American Act, the Berry Amendment, and Medical Marking Standard No. 1. Performance for this contract is centered in Fort Hood, Texas, under NAICS code 325412. Interested parties must have responded by the deadline of November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Permethrin Cream Rinse SupplyThis subcontract opportunity is for the manufacture or sourcing of pharmaceutical grade Permethrin Cream Rinse, identified by NSN 6505012564972, to support prime contractors on Department of Defense projects under the DLA Troop Support Medical Supply Chain Pharm FSA. The selected provider must possess a valid Unique Entity Identifier and CAGE code to be eligible. All products must be delivered in suitable sealed unit containers designed to prevent damage or breakage during transport. The project is categorized under NAICS code 325412 and will be performed at Fort Hood, Texas. Interested parties must submit their responses by November 18, 2026, following the posting date of November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Pad Supply (NSN 6510-01-047-5619)This subcontract involves the manufacture or sourcing of medical pads under NSN 6510-01-047-5619 to support prime contractors on DLA Troop Support Medical Supply Chain projects for the Department of Defense. The requirement specifies the delivery of three jars, each containing 40 units, to a government destination in FPO 96663. All shipments must be marked and labeled in accordance with MIL-STD-129. Critical quality and timing constraints include a mandatory 36-month shelf life for the products and a delivery window within five months of the date of manufacture. The opportunity is categorized under NAICS code 325412, with a response deadline set for November 18, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Norgestrel and Ethinyl Estradiol TabletsThis subcontract involves the supply of USP-grade Norgestrel and Ethinyl Estradiol tablets to support prime contractors for the Department of Defense Medical Supply Chain. The contractor is responsible for manufacturing or sourcing tablets of domestic origin that strictly adhere to United States Pharmacopeia standards, utilizing compliant manufacturing and packaging facilities. The specific requirement is for the delivery of 1,000 PG of tablets as outlined in the CLIN 0001 specifications. Managed by the Medical Supply Chain Pharm FSA under NAICS code 325412, the performance of this contract is centered in Fort Hood, Texas. Interested parties must adhere to the timeline established by the posting date of November 12, 2026, with a response deadline set for November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days

AI Contract Overview

The Government of Canada, through the Department of Public Works and Government Services, is seeking a contractor to manufacture and supply critical medical countermeasures for its public health emergency stockpile. The requirement consists of 73,500 vials of a sterile 0.2% phenol, phosphate-citrate based buffered diluent containing 45% glycerol in 2 mL labelled vials, along with 11,000 empty 2 mL labelled sterile glass vials featuring a removable cap enclosure system capable of being re-stoppered. All products must be manufactured in accordance with Canada's Food and Drug Regulations, specifically Part C, Division 2 current Good Manufacturing Practices, to ensure they are of sufficient quality for human use. This solicitation, numbered WS4617512505, was posted on January 31, 2025, with a response deadline of February 20, 2025. Performance of the contract is associated with the National Capital Region.

General Info

Canada seeks a contractor for medical diluents and sterile vials for emergency stockpiles.

Agency

Government of Canada → Department of Public Works and Government Services

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

*National Capital Region (NCR), CAN

Set-Aside

NONE

Documents

No documents available

No documents were posted with this contract.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update

PhaseClosed

PostedJun 3

Solicitation

Notice updatedJan 31

Response deadline changed from Jul 3, 2024 to Feb 20, 2025. The notice title changed. The notice description changed.

Response DeadlineFeb 20

Deadline has passed

Submission Closed

02/20/2025, 02:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Department of Public Works and Government Services

Contacts1 person available

OfficeN/A

Organization / AgencyGovernment of Canada → Department of Public Works and Government Services

Office AddressN/A

Contacts

Vettoretti Eric (SPAC/PSPCPoint of Contact

Full Description

Canada must procure and maintain a stockpile of medical countermeasures (MCM), including diluent and sterile empty glass vials required for vaccination, to support response to Canadian public health emergencies and events. The Government of Canada has a requirement for the services of a Contractor to manufacture and supply 73,500 vials of a sterile 0.2% phenol, phosphate-citrate based buffered diluent containing 45% glycerol (pH 7.4) in 2 mL labelled vials, accompanied by 11,000 empty 2mL labelled sterile glass vials with a removable cap enclosure system capable of being re-stoppered, in accordance with the technical specifications set out in Appendix A of this solicitation. The diluent and empty vials must be manufactured in accordance with Canada’s Food and Drug Regulations, Part C, Division 2 - current Good Manufacturing Practices (GMP), and be of sufficient quality for use in humans.